Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
McKesson
Harvard Business School
Fuji
QuintilesIMS
Fish and Richardson
Boehringer Ingelheim
Johnson and Johnson
Merck

Generated: June 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 022067

« Back to Dashboard

NDA 022067 describes FLO-PRED, which is a drug marketed by Taro and is included in one NDA. It is available from one supplier. There are four patents protecting this drug. Additional details are available on the FLO-PRED profile page.

The generic ingredient in FLO-PRED is prednisolone acetate. There are eighty-six drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the prednisolone acetate profile page.
Summary for 022067
Pharmacology for NDA: 022067
Suppliers and Packaging for NDA: 022067
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
FLO-PRED prednisolone acetate SUSPENSION;ORAL 022067 NDA Taro Pharmaceuticals U.S.A., Inc. 51672-1338 N 51672-1338-3
FLO-PRED prednisolone acetate SUSPENSION;ORAL 022067 NDA Taro Pharmaceuticals U.S.A., Inc. 51672-1338 N 51672-1338-5

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:SUSPENSION;ORALStrengthEQ 5MG BASE/5ML
Approval Date:Jan 17, 2008TE:RLD:No
Patent:➤ Sign UpPatent Expiration:Jun 3, 2018Product Flag?YSubstance Flag?Delist Request?
Patent:➤ Sign UpPatent Expiration:Jun 3, 2018Product Flag?YSubstance Flag?Delist Request?
Patent:➤ Sign UpPatent Expiration:Jun 3, 2018Product Flag?YSubstance Flag?Delist Request?

Expired US Patents for NDA 022067

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Taro FLO-PRED prednisolone acetate SUSPENSION;ORAL 022067-001 Jan 17, 2008 ➤ Sign Up ➤ Sign Up
Taro FLO-PRED prednisolone acetate SUSPENSION;ORAL 022067-001 Jan 17, 2008 ➤ Sign Up ➤ Sign Up
Taro FLO-PRED prednisolone acetate SUSPENSION;ORAL 022067-001 Jan 17, 2008 ➤ Sign Up ➤ Sign Up
Taro FLO-PRED prednisolone acetate SUSPENSION;ORAL 022067-001 Jan 17, 2008 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
UBS
Teva
US Department of Justice
AstraZeneca
Argus Health
Boehringer Ingelheim
Chinese Patent Office
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.